Press Releases

Novo Nordisk will extend its use of SomaLogic’s innovative proteomics technologies for research in cardiometabolic and other diseases BOULDER, Colo., Sept. 05, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, announced today that it is extending its collaborative
Sep 05, 2023
Revenue of $20.5 million, an increase of 45% year-over-year Cash and investments of approximately $474 million, a strong capital position to fund current and future business initiatives Reiterating full year 2023 revenue guidance and operating expense target Management to host conference call today
Aug 14, 2023
International designation signifies recognized standard for quality, reliability and competence in medical labs BOULDER, Colo. (June 21, 2023) — SomaLogic, Inc., a leader in proteomics technology, announced today that the company received the ISO 15189 accreditation, achieving all the requirements
Jun 21, 2023
Appoints Eliot M. Lurier, CPA, as Interim Chief Financial Officer Reaffirms 2023 Financial Guidance BOULDER, Colo., June 06, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc. (Nasdaq: SLGC), a leader in proteomics technology, today announced a Chief Financial Officer transition. Eliot M.
Jun 06, 2023
BOULDER, Colo., May 24, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced that the company will be participating in the upcoming Jefferies Healthcare Conference. SomaLogic management is scheduled to participate in a fireside chat on Wednesday, June 7,
May 24, 2023
Displaying 1 - 10 of 19